Rock Springs Capital Management LP Akero Therapeutics, Inc. Call Options Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
212Shares Held
67.8MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$295 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$260 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$240 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$225 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$186 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...